HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsune Tanimoto Selected Research

Mitsune Tanimoto Research Topics

Disease

77Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2020 - 03/2002
71Neoplasms (Cancer)
02/2022 - 03/2002
62Lung Neoplasms (Lung Cancer)
10/2017 - 03/2002
26Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2016 - 05/2002
19Inflammation (Inflammations)
01/2019 - 04/2005
15Leukemia
01/2017 - 04/2002
14Graft vs Host Disease (Graft-Versus-Host Disease)
02/2018 - 04/2002
13Lymphoma (Lymphomas)
10/2014 - 04/2002
11Disease Progression
11/2017 - 05/2005
11Respiratory Hypersensitivity
06/2016 - 04/2005
10Interstitial Lung Diseases (Interstitial Lung Disease)
06/2010 - 03/2003
10Adenocarcinoma
01/2009 - 03/2002
9Neoplasm Metastasis (Metastasis)
07/2020 - 03/2002
9Asthma (Bronchial Asthma)
12/2017 - 09/2006
9BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2017 - 01/2003
8Bronchiolitis Obliterans Syndrome
01/2017 - 02/2007
8Febrile Neutropenia
01/2015 - 01/2004
8Infections
05/2014 - 08/2002
7Hematologic Neoplasms (Hematological Malignancy)
08/2017 - 01/2004
7Fibrosis (Cirrhosis)
01/2012 - 03/2003
6Pneumonia (Pneumonitis)
11/2016 - 05/2005
6Malignant Pleural Effusion
10/2014 - 02/2007
5B-Cell Lymphoma (Lymphoma, B Cell)
09/2021 - 12/2002
5Emphysema
01/2019 - 01/2013
5Pleural Effusion (Pleural Effusions)
06/2017 - 08/2011
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017 - 06/2004
5Fever (Fevers)
08/2016 - 08/2002
5Carcinogenesis
08/2016 - 09/2008
5Adenocarcinoma of Lung
10/2014 - 07/2005
5Neutropenia
08/2012 - 07/2004
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2017 - 01/2003
4Carcinoma (Carcinomatosis)
01/2017 - 10/2002
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2015 - 04/2009
4Hyperplasia
07/2014 - 04/2005
4Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
05/2014 - 12/2003
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2011 - 03/2002
3Brain Neoplasms (Brain Tumor)
07/2020 - 11/2004
3Pulmonary Emphysema
01/2019 - 01/2013
3T-Cell Lymphoma (Lymphoma, T Cell)
12/2017 - 04/2014

Drug/Important Bio-Agent (IBA)

43Gefitinib (Iressa)FDA Link
11/2016 - 04/2003
38ErbB Receptors (EGF Receptor)IBA
07/2020 - 01/2004
36Cisplatin (Platino)FDA LinkGeneric
10/2016 - 03/2002
26Tyrosine Kinase InhibitorsIBA
11/2017 - 01/2004
15Irinotecan (Camptosar)FDA LinkGeneric
07/2012 - 01/2003
11Docetaxel (Taxotere)FDA Link
04/2012 - 07/2004
10Pharmaceutical PreparationsIBA
04/2022 - 06/2002
10Doxorubicin (Adriamycin)FDA LinkGeneric
12/2017 - 01/2003
10AntigensIBA
01/2017 - 08/2002
9Carboplatin (JM8)FDA LinkGeneric
10/2017 - 05/2002
9CytokinesIBA
06/2016 - 03/2002
8OvalbuminIBA
12/2017 - 09/2006
8Etoposide (VP 16)FDA LinkGeneric
12/2017 - 05/2002
8Imatinib Mesylate (Gleevec)FDA Link
06/2017 - 05/2007
8Proteins (Proteins, Gene)FDA Link
06/2016 - 11/2002
8Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2016 - 01/2010
7PlatinumIBA
01/2017 - 06/2002
7AllergensIBA
01/2014 - 09/2006
6Rituximab (Mabthera)FDA Link
09/2021 - 11/2007
6Pancreatic Elastase (Elastase)IBA
01/2019 - 01/2013
6Indicators and Reagents (Reagents)IBA
11/2017 - 10/2002
6IfosfamideFDA LinkGeneric
05/2009 - 03/2002
6DNA (Deoxyribonucleic Acid)IBA
09/2008 - 08/2003
6Interleukin-8 (Interleukin 8)IBA
07/2007 - 01/2003
6Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
07/2007 - 10/2002
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2017 - 06/2007
5Topotecan (Hycamtin)FDA LinkGeneric
10/2016 - 06/2006
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2016 - 09/2002
5Biomarkers (Surrogate Marker)IBA
01/2015 - 09/2008
5Messenger RNA (mRNA)IBA
07/2014 - 04/2002
5Paclitaxel (Taxol)FDA LinkGeneric
05/2014 - 07/2004
5amrubicinIBA
07/2012 - 05/2005
4Vincristine (Oncovin)FDA LinkGeneric
12/2017 - 05/2008
4Prednisone (Sone)FDA LinkGeneric
12/2017 - 01/2006
4Reactive Oxygen Species (Oxygen Radicals)IBA
03/2017 - 10/2002
4Bevacizumab (Avastin)FDA Link
01/2017 - 05/2013
4AfatinibIBA
01/2017 - 05/2013
4Interleukin-2 (IL2)IBA
01/2017 - 03/2002
4Phosphotransferases (Kinase)IBA
03/2016 - 01/2004
4ChemokinesIBA
04/2015 - 07/2005
4ParaffinIBA
09/2014 - 04/2009
4Anti-Bacterial Agents (Antibiotics)IBA
06/2014 - 01/2004
4Vindesine (Vindesin)IBA
06/2011 - 03/2002
4Fluorouracil (Carac)FDA LinkGeneric
01/2011 - 03/2003
4GemcitabineFDA Link
04/2008 - 03/2006
3Interleukin-17 (Interleukin 17)IBA
01/2019 - 01/2013
3Chemotactic FactorsIBA
01/2019 - 01/2003
3Tacrolimus (Prograf)FDA LinkGeneric
02/2018 - 06/2006
3Anaplastic Lymphoma KinaseIBA
12/2017 - 03/2016

Therapy/Procedure

63Drug Therapy (Chemotherapy)
09/2021 - 03/2002
47Therapeutics
02/2022 - 08/2002
13Hematopoietic Stem Cell Transplantation
01/2017 - 04/2002
12Radiotherapy
10/2016 - 05/2002
12Cell Transplantation
10/2016 - 06/2004
10Transplantation
08/2017 - 09/2003
9Chemoradiotherapy
03/2018 - 12/2003
9Combination Drug Therapy (Combination Chemotherapy)
01/2012 - 03/2002
7Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2014 - 01/2005
5Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
05/2006 - 08/2002
4Aftercare (After-Treatment)
02/2022 - 10/2006
4Adjuvant Chemotherapy
01/2012 - 10/2004